RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • March 1st, 2017 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • Washington
Unless otherwise defined herein, the terms defined in the 2014 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Restricted Stock Unit Award Agreement, including the Notice of Grant of Restricted Stock Units (the “Notice of Grant”), the Terms and Conditions of Restricted Stock Unit Grant, and any appendices and exhibits attached thereto (all together, the “Award Agreement”).
JUNO THERAPEUTICS, INC. INDEPENDENT CONTRACTOR AGREEMENTIndependent Contractor Agreement • March 1st, 2017 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Independent Contractor Agreement is made and entered into as of January 1, 2016 (“Effective Date”) between Juno Therapeutics, Inc., a Delaware corporation (“Company”), and Richard Klausner (“Contractor”). In consideration of the mutual promises contained in this Agreement, the parties agree as follows:
THIRD AMENDMENT TO LEASE AGREEMENTLease Agreement • March 1st, 2017 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances)
THIS THIRD AMENDMENT TO LEASE AGREEMENT (this “Third Amendment”) is made as of November 17, 2016 (“Amendment Effective Date”), by and between ARE-SEATTLE NO. 16, LLC, a Delaware limited liability company (“Landlord”), and JUNO THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
